000 | 01566 a2200421 4500 | ||
---|---|---|---|
005 | 20250513190054.0 | ||
264 | 0 | _c20000114 | |
008 | 200001s 0 0 ger d | ||
022 | _a1018-8843 | ||
024 | 7 |
_a10.1159/000022290 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFehr, M K | |
245 | 0 | 0 |
_a[Chemotherapy of endometrial cancer revisited]. _h[electronic resource] |
260 |
_bGynakologisch-geburtshilfliche Rundschau _c1999 |
||
300 |
_a110-20 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 |
_aAdenocarcinoma, Clear Cell _xdrug therapy |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCystadenocarcinoma, Papillary _xdrug therapy |
650 | 0 | 4 |
_aEndometrial Neoplasms _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHormones _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aWight, E | |
700 | 1 | _aHaller, U | |
773 | 0 |
_tGynakologisch-geburtshilfliche Rundschau _gvol. 39 _gno. 3 _gp. 110-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000022290 _zAvailable from publisher's website |
999 |
_c10378046 _d10378046 |